Sort
82,697 grants matching “vaccine development”
Activated Sugars, Oligosaccharides and Glycans for Antiviral Research
$982,971Leila Aminova · Midwest Bioprocessing Center, Llc · R44 · FY2021 · GM
Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses
$982,950Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2020 · AI
Human Responses to Candidate Chlamydial Antigens
$982,917Toni Darville · Univ Of North Carolina Chapel Hill · U19 · FY2023 · AI
Operations Core
$982,724William Paul Duprex · University Of Pittsburgh At Pittsburgh · UC7 · FY2025 · AI
A Therapeutic Vaccine for Chronic Hepatitis B
$982,569David R. Milich · Vlp Biotech, Inc. · R44 · FY2013 · AI
Expanding the Market and Success Rates for Myeloablative Cancer Treatments Using PUL-042, an Innate Immune Stimulant
$982,488Brenton Scott · Pulmotect, Inc · R44 · FY2015 · HL
Novel Plasmodial Surface Anion Channel Inhibitors as Antimalarial Drugs
$982,478Michelle M. Butler · Microbiotix, Inc · R44 · FY2021 · AI
4-(Aminomethyl) benzamides as novel anti-Ebola agents
$982,388Lijun Rong · Chicago Biosolutions, Inc. · R42 · FY2021 · AI
Novel DNA Repair Inhibitors for Cancer Therapy
$982,379Peter M Glazer · Yale University · R35 · FY2023 · CA
Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector
$982,311David A Williams · Boston Children'S Hospital · U01 · FY2020 · AI
CARIBBEAN PRIMATE RESEARCH CENTER PROGRAM
$982,256Edmundo Nelson Kraiselburd · University Of Puerto Rico Med Sciences · P40 · FY2007 · RR
Northwestern University O'Brien Kidney National Resource Center
$982,232Susan E Quaggin · Northwestern University At Chicago · U54 · FY2024 · DK
Nipah & Hendra Virus Nonhuman Primate Model & Therapeutics Development
$982,178Thomas William Geisbert · University Of Texas Med Br Galveston · U01 · FY2010 · AI
Vaccine Studies of Simian Immunodeficiency Virus (SIV) in Macaques
$982,177Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Pathogenesis Studies Of Simian Immunodeficiency Virus Infection Of Monkeys
$982,177Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Task C10: Enhancing Effectiveness of MVA Vector Vaccines
$982,091Mary Bruce · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2011 · AI
Development of a Novel CEA Expressing Ad5 [E1-, E2b-] Vector for Treatment
$982,054Frank R. Jones · Etubics Corporation · R44 · FY2010 · CA
Development Of New Approaches To Vaccines Against TBEV and West Nile Virus
$982,023Alexander Pletnev · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Boston Pediatric AIDS Clinical Trials Unit
$981,946Children'S Hospital Boston · U01 · FY2004 · AI
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine
$981,917Amit Praful Khandhar · Hdt Bio Corporation · R33 · FY2024 · AI
Clinical Trials of Haploidentical Hematopoietic Stem Cell Transplantation and Vac
$981,749Nelson J. Chao · Duke University · P01 · FY2010 · CA
Immune Deficient Mosquitoes for Improved Malaria Sporozoite Vaccine Manufacture
$981,741Peter F. Billingsley · Sanaria, Inc. · R44 · FY2018 · AI
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine
$981,683Amit Praful Khandhar · Hdt Bio Corporation · R33 · FY2025 · AI
MAPs for Peds: Development of a Microarray Patch for Delivery of Long-Acting Antiretrovirals for Treatment of Pediatric HIV Infection
$981,583Robert Kwai Ming Choy · Path · R33 · FY2023 · AI
A Therapeutic Vaccine for Chronic Hepatitis B
$981,428David R. Milich · Vlp Biotech, Inc. · R44 · FY2014 · AI